Literature DB >> 27448109

Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma.

James D Nolin1, H Luke Ogden1, Ying Lai1, William A Altemeier1, Charles W Frevert1,2, James G Bollinger3, Gajendra S Naika3, Anthony Kicic4,5,6,7, Stephen M Stick4,5,6,7, Gerard Lambeau8, William R Henderson9, Michael H Gelb3,10, Teal S Hallstrand1.   

Abstract

Secreted phospholipase A2s (sPLA2s) regulate eicosanoid formation and have been implicated in asthma. Although sPLA2s function as enzymes, some of the sPLA2s bind with high affinity to a C-type lectin receptor, called PLA2R1, which has functions in both cellular signaling and clearance of sPLA2s. We sought to examine the expression of PLA2R1 in the airway epithelium of human subjects with asthma and the function of the murine Pla2r1 gene in a model of asthma. Expression of PLA2R1 in epithelial brushings was assessed in two distinct cohorts of children with asthma by microarray and quantitative PCR, and immunostaining for PLA2R1 was conducted on endobronchial tissue and epithelial brushings from adults with asthma. C57BL/129 mice deficient in Pla2r1 (Pla2r1-/-) were characterized in an ovalbumin (OVA) model of allergic asthma. PLA2R1 was differentially overexpressed in epithelial brushings of children with atopic asthma in both cohorts. Immunostaining for PLA2R1 in endobronchial tissue localized to submucosal glandular epithelium and columnar epithelial cells. After OVA sensitization and challenge, Pla2r1-/- mice had increased airway hyperresponsiveness, as well as an increase in cellular trafficking of eosinophils to the peribronchial space and bronchoalveolar lavage fluid, and an increase in airway permeability. In addition, Pla2r1-/- mice had more dendritic cells in the lung, higher levels of OVA-specific IgG, and increased production of both type-1 and type-2 cytokines by lung leukocytes. PLA2R1 is increased in the airway epithelium in asthma, and serves as a regulator of airway hyperresponsiveness, airway permeability, antigen sensitization, and airway inflammation.

Entities:  

Keywords:  C-type lectin; allergy; asthma; phospholipase A2; phospholipase A2 receptor 1

Mesh:

Substances:

Year:  2016        PMID: 27448109      PMCID: PMC5248949          DOI: 10.1165/rcmb.2015-0150OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  46 in total

Review 1.  The C-type lectin-like domain superfamily.

Authors:  Alex N Zelensky; Jill E Gready
Journal:  FEBS J       Date:  2005-12       Impact factor: 5.542

2.  Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor.

Authors:  Morgane Rouault; Catherine Le Calvez; Eric Boilard; Fanny Surrel; Alan Singer; Farideh Ghomashchi; Sofiane Bezzine; Sabine Scarzello; James Bollinger; Michael H Gelb; Gérard Lambeau
Journal:  Biochemistry       Date:  2007-02-13       Impact factor: 3.162

3.  Expression of enhancing factor/phospholipase A2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis.

Authors:  Rita Mulherkar; Bhakti M Kirtane; Asha Ramchandani; Nirmala P Mansukhani; Sadhana Kannan; Kikkeri N Naresh
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

4.  Characterization and differentiation-dependent regulation of secreted phospholipases A in human keratinocytes and in healthy and psoriatic human skin.

Authors:  Ulrike Haas; Maurizio Podda; Martin Behne; Silvia Gurrieri; Angel Alonso; Gerhard Fürstenberger; Josef Pfeilschifter; Gérard Lambeau; Michael H Gelb; Marietta Kaszkin
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

5.  Relationship between levels of secreted phospholipase A₂ groups IIA and X in the airways and asthma severity.

Authors:  T S Hallstrand; Y Lai; Z Ni; R C Oslund; W R Henderson; M H Gelb; S E Wenzel
Journal:  Clin Exp Allergy       Date:  2011-01-24       Impact factor: 5.018

6.  A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.

Authors:  William R Henderson; Li-Ou Tang; Shi-Jye Chu; Shih-Ming Tsao; Gertrude K S Chiang; Falaah Jones; Mechthild Jonas; Chong Pae; Huaijing Wang; Emil Y Chi
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

7.  sPLA2 and the epidermal barrier.

Authors:  Dusko Ilic; James M Bollinger; Michael Gelb; Theodora M Mauro
Journal:  Biochim Biophys Acta       Date:  2013-11-20

8.  Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model.

Authors:  William R Henderson; Emil Y Chi; James G Bollinger; Ying-tzang Tien; Xin Ye; Luca Castelli; Yuri P Rubtsov; Alan G Singer; Gertrude K S Chiang; Timo Nevalainen; Alexander Y Rudensky; Michael H Gelb
Journal:  J Exp Med       Date:  2007-04-02       Impact factor: 14.307

9.  Controls for immunohistochemistry: the Histochemical Society's standards of practice for validation of immunohistochemical assays.

Authors:  Stephen M Hewitt; Denis G Baskin; Charles W Frevert; William L Stahl; Eduardo Rosa-Molinar
Journal:  J Histochem Cytochem       Date:  2014-07-14       Impact factor: 2.479

10.  Key role of group v secreted phospholipase A2 in Th2 cytokine and dendritic cell-driven airway hyperresponsiveness and remodeling.

Authors:  William R Henderson; Xin Ye; Ying Lai; Zhanglin Ni; James G Bollinger; Ying-Tzang Tien; Emil Y Chi; Michael H Gelb
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more
  9 in total

1.  Secreted Phospholipase A2 Group X Acts as an Adjuvant for Type 2 Inflammation, Leading to an Allergen-Specific Immune Response in the Lung.

Authors:  Herbert Luke Ogden; Ying Lai; James D Nolin; Dowon An; Charles W Frevert; Michael H Gelb; William A Altemeier; Teal S Hallstrand
Journal:  J Immunol       Date:  2020-04-27       Impact factor: 5.422

2.  Secreted PLA2 group X orchestrates innate and adaptive immune responses to inhaled allergen.

Authors:  James D Nolin; Ying Lai; Herbert Luke Ogden; Anne M Manicone; Ryan C Murphy; Dowon An; Charles W Frevert; Farideh Ghomashchi; Gajendra S Naika; Michael H Gelb; Gail M Gauvreau; Adrian M Piliponsky; William A Altemeier; Teal S Hallstrand
Journal:  JCI Insight       Date:  2017-11-02

Review 3.  Function of secreted phospholipase A2 group-X in asthma and allergic disease.

Authors:  James D Nolin; Ryan C Murphy; Michael H Gelb; William A Altemeier; William R Henderson; Teal S Hallstrand
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-12-05       Impact factor: 4.698

4.  Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation.

Authors:  Hong Dang; Deepika Polineni; Rhonda G Pace; Jaclyn R Stonebraker; Harriet Corvol; Garry R Cutting; Mitchell L Drumm; Lisa J Strug; Wanda K O'Neal; Michael R Knowles
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

Review 5.  PLA2R and THSD7A: Disparate Paths to the Same Disease?

Authors:  Laurence H Beck
Journal:  J Am Soc Nephrol       Date:  2017-07-03       Impact factor: 10.121

Review 6.  Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.

Authors:  Wenbin Liu; Chang Gao; Haoran Dai; Yang Zheng; Zhaocheng Dong; Yu Gao; Fei Liu; Zihan Zhang; Zhiyuan Liu; Weijing Liu; Baoli Liu; Qingquan Liu; Jialan Shi
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

Review 7.  Perspectives in membranous nephropathy.

Authors:  Nicola M Tomas; Tobias B Huber; Elion Hoxha
Journal:  Cell Tissue Res       Date:  2021-04-06       Impact factor: 4.051

8.  MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy.

Authors:  Xiaoshan Zhou; Haoran Dai; Hanxue Jiang; Hongliang Rui; Wenbin Liu; Zhaocheng Dong; Na Zhang; Qihan Zhao; Zhendong Feng; Yuehong Hu; Fanyu Hou; Yang Zheng; Baoli Liu
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

Review 9.  Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity.

Authors:  Wenbin Liu; Chang Gao; Zhiyuan Liu; Haoran Dai; Zhendong Feng; Zhaocheng Dong; Yang Zheng; Yu Gao; Xuefei Tian; Baoli Liu
Journal:  Front Immunol       Date:  2020-09-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.